nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—Rash generalised—Vemurafenib—skin cancer	0.0833	0.0833	CcSEcCtD
Carteolol—Cerebral ischaemia—Temozolomide—skin cancer	0.0374	0.0374	CcSEcCtD
Carteolol—Lacrimation—Fluorouracil—skin cancer	0.0284	0.0284	CcSEcCtD
Carteolol—Rash generalised—Docetaxel—skin cancer	0.0283	0.0283	CcSEcCtD
Carteolol—Dysgeusia—Vismodegib—skin cancer	0.0245	0.0245	CcSEcCtD
Carteolol—Cerebrovascular accident—Imiquimod—skin cancer	0.0224	0.0224	CcSEcCtD
Carteolol—Lacrimation—Docetaxel—skin cancer	0.0205	0.0205	CcSEcCtD
Carteolol—Eye irritation—Fluorouracil—skin cancer	0.0195	0.0195	CcSEcCtD
Carteolol—Respiratory failure—Temozolomide—skin cancer	0.0184	0.0184	CcSEcCtD
Carteolol—Lacrimation increased—Fluorouracil—skin cancer	0.0181	0.0181	CcSEcCtD
Carteolol—Depression—Imiquimod—skin cancer	0.0168	0.0168	CcSEcCtD
Carteolol—Conjunctivitis—Imiquimod—skin cancer	0.0164	0.0164	CcSEcCtD
Carteolol—Cerebrovascular accident—Bleomycin—skin cancer	0.0159	0.0159	CcSEcCtD
Carteolol—Sinusitis—Imiquimod—skin cancer	0.0158	0.0158	CcSEcCtD
Carteolol—Photophobia—Fluorouracil—skin cancer	0.0157	0.0157	CcSEcCtD
Carteolol—Dysgeusia—Vemurafenib—skin cancer	0.0152	0.0152	CcSEcCtD
Carteolol—Asthenia—Vismodegib—skin cancer	0.0147	0.0147	CcSEcCtD
Carteolol—Visual impairment—Imiquimod—skin cancer	0.0146	0.0146	CcSEcCtD
Carteolol—Eye irritation—Docetaxel—skin cancer	0.0141	0.0141	CcSEcCtD
Carteolol—Arrhythmia—Imiquimod—skin cancer	0.0135	0.0135	CcSEcCtD
Carteolol—Bronchospasm—Bleomycin—skin cancer	0.0132	0.0132	CcSEcCtD
Carteolol—Diplopia—Temozolomide—skin cancer	0.0131	0.0131	CcSEcCtD
Carteolol—Lacrimation increased—Docetaxel—skin cancer	0.0131	0.0131	CcSEcCtD
Carteolol—Respiratory failure—Docetaxel—skin cancer	0.0123	0.0123	CcSEcCtD
Carteolol—Nausea—Vismodegib—skin cancer	0.0121	0.0121	CcSEcCtD
Carteolol—Syncope—Imiquimod—skin cancer	0.0118	0.0118	CcSEcCtD
Carteolol—Hypotension—Vemurafenib—skin cancer	0.0118	0.0118	CcSEcCtD
Carteolol—Palpitations—Imiquimod—skin cancer	0.0117	0.0117	CcSEcCtD
Carteolol—Loss of consciousness—Imiquimod—skin cancer	0.0116	0.0116	CcSEcCtD
Carteolol—Oedema—Imiquimod—skin cancer	0.0108	0.0108	CcSEcCtD
Carteolol—Shock—Imiquimod—skin cancer	0.0106	0.0106	CcSEcCtD
Carteolol—Depression—Temozolomide—skin cancer	0.0101	0.0101	CcSEcCtD
Carteolol—Insomnia—Imiquimod—skin cancer	0.00974	0.00974	CcSEcCtD
Carteolol—Cardiac failure congestive—Docetaxel—skin cancer	0.00963	0.00963	CcSEcCtD
Carteolol—Dyspnoea—Imiquimod—skin cancer	0.0096	0.0096	CcSEcCtD
Carteolol—Sinusitis—Temozolomide—skin cancer	0.0095	0.0095	CcSEcCtD
Carteolol—Hypersensitivity—Vemurafenib—skin cancer	0.00931	0.00931	CcSEcCtD
Carteolol—Visual disturbance—Docetaxel—skin cancer	0.00922	0.00922	CcSEcCtD
Carteolol—Conjunctivitis—Fluorouracil—skin cancer	0.00907	0.00907	CcSEcCtD
Carteolol—Asthenia—Vemurafenib—skin cancer	0.00906	0.00906	CcSEcCtD
Carteolol—Visual impairment—Temozolomide—skin cancer	0.00876	0.00876	CcSEcCtD
Carteolol—Sinusitis—Fluorouracil—skin cancer	0.00875	0.00875	CcSEcCtD
Carteolol—Dizziness—Vemurafenib—skin cancer	0.00835	0.00835	CcSEcCtD
Carteolol—Hypersensitivity—Imiquimod—skin cancer	0.00794	0.00794	CcSEcCtD
Carteolol—Headache—Vemurafenib—skin cancer	0.00791	0.00791	CcSEcCtD
Carteolol—Dysgeusia—Temozolomide—skin cancer	0.00775	0.00775	CcSEcCtD
Carteolol—Asthenia—Imiquimod—skin cancer	0.00773	0.00773	CcSEcCtD
Carteolol—Oedema—Bleomycin—skin cancer	0.00765	0.00765	CcSEcCtD
Carteolol—Nausea—Vemurafenib—skin cancer	0.0075	0.0075	CcSEcCtD
Carteolol—Arrhythmia—Fluorouracil—skin cancer	0.00748	0.00748	CcSEcCtD
Carteolol—Vision blurred—Temozolomide—skin cancer	0.00745	0.00745	CcSEcCtD
Carteolol—Bronchospasm—Docetaxel—skin cancer	0.00743	0.00743	CcSEcCtD
Carteolol—Hypotension—Bleomycin—skin cancer	0.00715	0.00715	CcSEcCtD
Carteolol—Oedema—Dactinomycin—skin cancer	0.00714	0.00714	CcSEcCtD
Carteolol—Dizziness—Imiquimod—skin cancer	0.00712	0.00712	CcSEcCtD
Carteolol—Palpitations—Temozolomide—skin cancer	0.00699	0.00699	CcSEcCtD
Carteolol—Vision blurred—Fluorouracil—skin cancer	0.00687	0.00687	CcSEcCtD
Carteolol—Dyspnoea—Bleomycin—skin cancer	0.00682	0.00682	CcSEcCtD
Carteolol—Headache—Imiquimod—skin cancer	0.00675	0.00675	CcSEcCtD
Carteolol—Conjunctivitis—Docetaxel—skin cancer	0.00654	0.00654	CcSEcCtD
Carteolol—Oedema—Temozolomide—skin cancer	0.00646	0.00646	CcSEcCtD
Carteolol—Nausea—Imiquimod—skin cancer	0.0064	0.0064	CcSEcCtD
Carteolol—Oedema—Fluorouracil—skin cancer	0.00595	0.00595	CcSEcCtD
Carteolol—Insomnia—Temozolomide—skin cancer	0.00584	0.00584	CcSEcCtD
Carteolol—Visual impairment—Docetaxel—skin cancer	0.00582	0.00582	CcSEcCtD
Carteolol—Dyspnoea—Temozolomide—skin cancer	0.00576	0.00576	CcSEcCtD
Carteolol—Hypersensitivity—Bleomycin—skin cancer	0.00564	0.00564	CcSEcCtD
Carteolol—Hypotension—Fluorouracil—skin cancer	0.00556	0.00556	CcSEcCtD
Carteolol—Asthenia—Bleomycin—skin cancer	0.00549	0.00549	CcSEcCtD
Carteolol—Arrhythmia—Docetaxel—skin cancer	0.0054	0.0054	CcSEcCtD
Carteolol—Insomnia—Fluorouracil—skin cancer	0.00538	0.00538	CcSEcCtD
Carteolol—Dyspnoea—Fluorouracil—skin cancer	0.0053	0.0053	CcSEcCtD
Carteolol—Hypersensitivity—Dactinomycin—skin cancer	0.00526	0.00526	CcSEcCtD
Carteolol—Dysgeusia—Docetaxel—skin cancer	0.00515	0.00515	CcSEcCtD
Carteolol—Asthenia—Dactinomycin—skin cancer	0.00512	0.00512	CcSEcCtD
Carteolol—Hypersensitivity—Temozolomide—skin cancer	0.00476	0.00476	CcSEcCtD
Carteolol—Syncope—Docetaxel—skin cancer	0.00472	0.00472	CcSEcCtD
Carteolol—Palpitations—Docetaxel—skin cancer	0.00465	0.00465	CcSEcCtD
Carteolol—Asthenia—Temozolomide—skin cancer	0.00463	0.00463	CcSEcCtD
Carteolol—Loss of consciousness—Docetaxel—skin cancer	0.00462	0.00462	CcSEcCtD
Carteolol—Nausea—Bleomycin—skin cancer	0.00455	0.00455	CcSEcCtD
Carteolol—Hypersensitivity—Fluorouracil—skin cancer	0.00438	0.00438	CcSEcCtD
Carteolol—Oedema—Docetaxel—skin cancer	0.00429	0.00429	CcSEcCtD
Carteolol—Dizziness—Temozolomide—skin cancer	0.00427	0.00427	CcSEcCtD
Carteolol—Nausea—Dactinomycin—skin cancer	0.00424	0.00424	CcSEcCtD
Carteolol—Shock—Docetaxel—skin cancer	0.00422	0.00422	CcSEcCtD
Carteolol—Headache—Temozolomide—skin cancer	0.00404	0.00404	CcSEcCtD
Carteolol—Hypotension—Docetaxel—skin cancer	0.00401	0.00401	CcSEcCtD
Carteolol—Dizziness—Fluorouracil—skin cancer	0.00393	0.00393	CcSEcCtD
Carteolol—Insomnia—Docetaxel—skin cancer	0.00388	0.00388	CcSEcCtD
Carteolol—Nausea—Temozolomide—skin cancer	0.00383	0.00383	CcSEcCtD
Carteolol—Dyspnoea—Docetaxel—skin cancer	0.00383	0.00383	CcSEcCtD
Carteolol—Headache—Fluorouracil—skin cancer	0.00373	0.00373	CcSEcCtD
Carteolol—Nausea—Fluorouracil—skin cancer	0.00353	0.00353	CcSEcCtD
Carteolol—Hypersensitivity—Docetaxel—skin cancer	0.00316	0.00316	CcSEcCtD
Carteolol—Asthenia—Docetaxel—skin cancer	0.00308	0.00308	CcSEcCtD
Carteolol—Dizziness—Docetaxel—skin cancer	0.00284	0.00284	CcSEcCtD
Carteolol—Headache—Docetaxel—skin cancer	0.00269	0.00269	CcSEcCtD
Carteolol—Nausea—Docetaxel—skin cancer	0.00255	0.00255	CcSEcCtD
